According to the latest SEC filings, insiders at Vital Therapies, Inc. (NASDAQ:VTL) have increased their position in the stock by 40.22% over the past 6 months. Insiders now own 30.78% of total outstanding shares.
University of Michigan professor and noted insider trading researcher discovered that when insiders bought shares of their own companies, the stocks outperformed the total market by 8.9% over the next 12-month period. When they sold shares, the stock underperformed 5.4%.
Vital Therapies, Inc. (NASDAQ:VTL) stands -8.59% away from its 50-day simple moving average and also -34.92% away from the 200-day average. Recently, the equity stands -59.12% away from the 52-week high and 35.56% from the 52-week low. The RSI (Relative Strength Index), an indicator that shows price strength by comparing upward and downward close-to-close movements is 50.03.
Wall Street analysts on the sell-side covering shares of Vital Therapies, Inc. (NASDAQ:VTL) have a mean recommendation of 3.00 on the shares. This is based on a numerical chart where each stock recommendation (Buy,Sell,Hold) is translated into a numerical equivalent. A low number indicates a Buy and a higher number a Sell. In terms of where analysts see the stock headed, they have a consensus price target of $7.50 on the shares.